世界の新型コロナウイルス感染症ワクチン接種市場2023-2027

◆英語タイトル:Global Covid-19 Vaccination Market 2023-2027

Technavioが発行した調査報告書(IRTNTR71375-23)◆商品コード:IRTNTR71375-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年10月7日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、アジア、ヨーロッパ、その他地域
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の新型コロナウイルス感染症ワクチン接種市場 2023-2027
新型コロナウイルス感染症ワクチン接種市場は、2022年から2027年にかけて-54,598.89百万米ドルの成長が予測され、予測期間中のCAGRは-29.3%になると予測されています。
当レポートでは、新型コロナウイルス感染症ワクチン接種市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ワクチン接種プログラムの拡大、新たな新型コロナウイルス感染症の出現、新型コロナウイルス感染症ワクチン接種の対象拡大によって牽引されています。

Technavioの新型コロナウイルス感染症ワクチン接種市場は以下のように区分されます:

タイプ別:
- mRNA
- その他

流通チャネル別:
- 政府機関
- 病院・クリニック
- その他

地域別:
- 北米
- アジア
- ヨーロッパ
- その他の地域(ROW)

本調査では、今後数年間の新型コロナウイルス感染症ワクチン接種市場の成長を促進する主な理由の1つとして、研究開発投資の増加を挙げています。また、新しい新型コロナウイルス感染症ワクチン接種の発売、新型コロナウイルス感染症ワクチン接種市場における技術と革新の採用は、市場の大きな需要につながるでしょう。

この調査レポートは、新型コロナウイルス感染症ワクチン接種市場を分析・予測し、以下のてこ入れを行います:
- 新型コロナウイルス感染症ワクチン接種市場の規模
- 新型コロナウイルス感染症ワクチン接種市場の予測
- 新型コロナウイルス感染症ワクチン接種市場の産業分析

強固なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AIVITA Biomedical Inc., AnGes Inc., AstraZeneca Plc, Bharat Biotech Ltd., CureVac AG, Emergent BioSolutions Inc., Eubiologics Co. Ltd., Genexine Inc., GreenLight Biosciences Holdings PBC, Inovio Pharmaceuticals Inc., Johnson and Johnson, Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., Tadbir innovation pharmaceutical Co., The Gamaleya National Center, and Zydus Lifesciences Ltd.などの主要企業情報が含まれています。また、新型コロナウイルス感染症ワクチン接種市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。
本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細なイメージを提示しています。また、主要な産業インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1.エグゼクティブサマリー
2.市場状況
3.市場規模
4.ファイブフォース分析
5.新型コロナウイルス感染症ワクチン接種市場のセグメンテーション:種類別
6.新型コロナウイルス感染症ワクチン接種市場のセグメンテーション:流通チャネル別
7.顧客状況
8.地理的状況
9.推進要因・課題・傾向
10.企業状況
11.企業分析
12.付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary €“ Chart on Market Overview
o Exhibit 02: Executive Summary €“ Data Table on Market Overview
o Exhibit 03: Executive Summary €“ Chart on Global Market Characteristics
o Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary €“ Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary €“ Chart on Incremental Growth
o Exhibit 08: Executive Summary €“ Data Table on Incremental Growth
o Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 18: Five forces analysis – Comparison between 2022 and 2027
o 4.2 Bargaining power of buyers
o Exhibit 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
o 4.3 Bargaining power of suppliers
o Exhibit 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
o 4.4 Threat of new entrants
o Exhibit 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
o 4.5 Threat of substitutes
o Exhibit 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
o 4.6 Threat of rivalry
o Exhibit 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
o 4.7 Market condition
o Exhibit 24: Chart on Market condition – Five forces 2022 and 2027
• 5 Market Segmentation by Type
o 5.1 Market segments
o Exhibit 25: Chart on Type – Market share 2022-2027 (%)
o Exhibit 26: Data Table on Type – Market share 2022-2027 (%)
o 5.2 Comparison by Type
o Exhibit 27: Chart on Comparison by Type
o Exhibit 28: Data Table on Comparison by Type
o 5.3 mRNA – Market size and forecast 2022-2027
o Exhibit 29: Chart on mRNA – Market size and forecast 2022-2027 ($ million)
o Exhibit 30: Data Table on mRNA – Market size and forecast 2022-2027 ($ million)
o Exhibit 31: Chart on mRNA – Year-over-year growth 2022-2027 (%)
o Exhibit 32: Data Table on mRNA – Year-over-year growth 2022-2027 (%)
o 5.4 Others – Market size and forecast 2022-2027
o Exhibit 33: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 34: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 36: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 5.5 Market opportunity by Type
o Exhibit 37: Market opportunity by Type ($ million)
o Exhibit 38: Data Table on Market opportunity by Type ($ million)
• 6 Market Segmentation by Distribution Channel
o 6.1 Market segments
o Exhibit 39: Chart on Distribution Channel – Market share 2022-2027 (%)
o Exhibit 40: Data Table on Distribution Channel – Market share 2022-2027 (%)
o 6.2 Comparison by Distribution Channel
o Exhibit 41: Chart on Comparison by Distribution Channel
o Exhibit 42: Data Table on Comparison by Distribution Channel
o 6.3 Government entities – Market size and forecast 2022-2027
o Exhibit 43: Chart on Government entities – Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Data Table on Government entities – Market size and forecast 2022-2027 ($ million)
o Exhibit 45: Chart on Government entities – Year-over-year growth 2022-2027 (%)
o Exhibit 46: Data Table on Government entities – Year-over-year growth 2022-2027 (%)
o 6.4 Hospitals and clinics – Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
o 6.5 Others – Market size and forecast 2022-2027
o Exhibit 51: Chart on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Others – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Others – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Others – Year-over-year growth 2022-2027 (%)
o 6.6 Market opportunity by Distribution Channel
o Exhibit 55: Market opportunity by Distribution Channel ($ million)
o Exhibit 56: Data Table on Market opportunity by Distribution Channel ($ million)
• 7 Customer Landscape
o 7.1 Customer landscape overview
o Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 8 Geographic Landscape
o 8.1 Geographic segmentation
o Exhibit 58: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 59: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 8.2 Geographic comparison
o Exhibit 60: Chart on Geographic comparison
o Exhibit 61: Data Table on Geographic comparison
o 8.3 North America – Market size and forecast 2022-2027
o Exhibit 62: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 65: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 8.4 Asia – Market size and forecast 2022-2027
o Exhibit 66: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 69: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 8.5 Europe – Market size and forecast 2022-2027
o Exhibit 70: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 73: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 8.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 74: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 77: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 8.7 US – Market size and forecast 2022-2027
o Exhibit 78: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 81: Data Table on US – Year-over-year growth 2022-2027 (%)
o 8.8 China – Market size and forecast 2022-2027
o Exhibit 82: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 85: Data Table on China – Year-over-year growth 2022-2027 (%)
o 8.9 Japan – Market size and forecast 2022-2027
o Exhibit 86: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 89: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 8.10 UK – Market size and forecast 2022-2027
o Exhibit 90: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 93: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 8.11 Germany – Market size and forecast 2022-2027
o Exhibit 94: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 97: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 8.12 Market opportunity By Geographical Landscape
o Exhibit 98: Market opportunity By Geographical Landscape ($ million)
o Exhibit 99: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 9 Drivers, Challenges, and Trends
o 9.1 Market drivers
o 9.2 Market challenges
o 9.3 Impact of drivers and challenges
o Exhibit 100: Impact of drivers and challenges in 2022 and 2027
o 9.4 Market trends
• 10 Vendor Landscape
o 10.1 Overview
o 10.2 Vendor landscape
o Exhibit 101: Overview on Criticality of inputs and Factors of differentiation
o 10.3 Landscape disruption
o Exhibit 102: Overview on factors of disruption
o 10.4 Industry risks
o Exhibit 103: Impact of key risks on business
• 11 Vendor Analysis
o 11.1 Vendors covered
o Exhibit 104: Vendors covered
o 11.2 Market positioning of vendors
o Exhibit 105: Matrix on vendor position and classification
o 11.3 AstraZeneca Plc
o Exhibit 106: AstraZeneca Plc – Overview
o Exhibit 107: AstraZeneca Plc – Product / Service
o Exhibit 108: AstraZeneca Plc – Key news
o Exhibit 109: AstraZeneca Plc – Key offerings
o 11.4 Bharat Biotech Ltd.
o Exhibit 110: Bharat Biotech Ltd. – Overview
o Exhibit 111: Bharat Biotech Ltd. – Product / Service
o Exhibit 112: Bharat Biotech Ltd. – Key news
o Exhibit 113: Bharat Biotech Ltd. – Key offerings
o 11.5 CureVac AG
o Exhibit 114: CureVac AG – Overview
o Exhibit 115: CureVac AG – Key offerings
o 11.6 Emergent BioSolutions Inc.
o Exhibit 116: Emergent BioSolutions Inc. – Overview
o Exhibit 117: Emergent BioSolutions Inc. – Product / Service
o Exhibit 118: Emergent BioSolutions Inc. – Key news
o Exhibit 119: Emergent BioSolutions Inc. – Key offerings
o 11.7 Genexine Inc.
o Exhibit 120: Genexine Inc. – Overview
o Exhibit 121: Genexine Inc. – Product / Service
o Exhibit 122: Genexine Inc. – Key offerings
o 11.8 Inovio Pharmaceuticals Inc.
o Exhibit 123: Inovio Pharmaceuticals Inc. – Overview
o Exhibit 124: Inovio Pharmaceuticals Inc. – Product / Service
o Exhibit 125: Inovio Pharmaceuticals Inc. – Key news
o Exhibit 126: Inovio Pharmaceuticals Inc. – Key offerings
o 11.9 Johnson and Johnson
o Exhibit 127: Johnson and Johnson – Overview
o Exhibit 128: Johnson and Johnson – Business segments
o Exhibit 129: Johnson and Johnson – Key news
o Exhibit 130: Johnson and Johnson – Key offerings
o Exhibit 131: Johnson and Johnson – Segment focus
o 11.10 Moderna Inc.
o Exhibit 132: Moderna Inc. – Overview
o Exhibit 133: Moderna Inc. – Product / Service
o Exhibit 134: Moderna Inc. – Key offerings
o 11.11 Novavax Inc.
o Exhibit 135: Novavax Inc. – Overview
o Exhibit 136: Novavax Inc. – Product / Service
o Exhibit 137: Novavax Inc. – Key offerings
o 11.12 Pfizer Inc.
o Exhibit 138: Pfizer Inc. – Overview
o Exhibit 139: Pfizer Inc. – Product / Service
o Exhibit 140: Pfizer Inc. – Key news
o Exhibit 141: Pfizer Inc. – Key offerings
o 11.13 Serum Institute of India Pvt. Ltd.
o Exhibit 142: Serum Institute of India Pvt. Ltd. – Overview
o Exhibit 143: Serum Institute of India Pvt. Ltd. – Product / Service
o Exhibit 144: Serum Institute of India Pvt. Ltd. – Key offerings
o 11.14 Shenzhen Kangtai Biological Products Co. Ltd.
o Exhibit 145: Shenzhen Kangtai Biological Products Co. Ltd. – Overview
o Exhibit 146: Shenzhen Kangtai Biological Products Co. Ltd. – Product / Service
o Exhibit 147: Shenzhen Kangtai Biological Products Co. Ltd. – Key offerings
o 11.15 Sinovac Biotech Ltd.
o Exhibit 148: Sinovac Biotech Ltd. – Overview
o Exhibit 149: Sinovac Biotech Ltd. – Product / Service
o Exhibit 150: Sinovac Biotech Ltd. – Key offerings
o 11.16 Tadbir innovation pharmaceutical Co.
o Exhibit 151: Tadbir innovation pharmaceutical Co. – Overview
o Exhibit 152: Tadbir innovation pharmaceutical Co. – Product / Service
o Exhibit 153: Tadbir innovation pharmaceutical Co. – Key offerings
o 11.17 Zydus Lifesciences Ltd.
o Exhibit 154: Zydus Lifesciences Ltd. – Overview
o Exhibit 155: Zydus Lifesciences Ltd. – Business segments
o Exhibit 156: Zydus Lifesciences Ltd. – Key offerings
o Exhibit 157: Zydus Lifesciences Ltd. – Segment focus
• 12 Appendix
o 12.1 Scope of the report
o 12.2 Inclusions and exclusions checklist
o Exhibit 158: Inclusions checklist
o Exhibit 159: Exclusions checklist
o 12.3 Currency conversion rates for US$
o Exhibit 160: Currency conversion rates for US$
o 12.4 Research methodology
o Exhibit 161: Research methodology
o Exhibit 162: Validation techniques employed for market sizing
o Exhibit 163: Information sources
o 12.5 List of abbreviations
o Exhibit 164: List of abbreviations

Exhibits:
Exhibits1: Executive Summary €“ Chart on Market Overview
Exhibits2: Executive Summary €“ Data Table on Market Overview
Exhibits3: Executive Summary €“ Chart on Global Market Characteristics
Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape
Exhibits5: Executive Summary €“ Chart on Market Segmentation by Type
Exhibits6: Executive Summary €“ Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary €“ Chart on Incremental Growth
Exhibits8: Executive Summary €“ Data Table on Incremental Growth
Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Five forces analysis – Comparison between 2022 and 2027
Exhibits19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027
Exhibits20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027
Exhibits21: Threat of new entrants €“ Impact of key factors in 2022 and 2027
Exhibits22: Threat of substitutes €“ Impact of key factors in 2022 and 2027
Exhibits23: Threat of rivalry €“ Impact of key factors in 2022 and 2027
Exhibits24: Chart on Market condition – Five forces 2022 and 2027
Exhibits25: Chart on Type – Market share 2022-2027 (%)
Exhibits26: Data Table on Type – Market share 2022-2027 (%)
Exhibits27: Chart on Comparison by Type
Exhibits28: Data Table on Comparison by Type
Exhibits29: Chart on mRNA – Market size and forecast 2022-2027 ($ million)
Exhibits30: Data Table on mRNA – Market size and forecast 2022-2027 ($ million)
Exhibits31: Chart on mRNA – Year-over-year growth 2022-2027 (%)
Exhibits32: Data Table on mRNA – Year-over-year growth 2022-2027 (%)
Exhibits33: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits34: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits35: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits36: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits37: Market opportunity by Type ($ million)
Exhibits38: Data Table on Market opportunity by Type ($ million)
Exhibits39: Chart on Distribution Channel – Market share 2022-2027 (%)
Exhibits40: Data Table on Distribution Channel – Market share 2022-2027 (%)
Exhibits41: Chart on Comparison by Distribution Channel
Exhibits42: Data Table on Comparison by Distribution Channel
Exhibits43: Chart on Government entities – Market size and forecast 2022-2027 ($ million)
Exhibits44: Data Table on Government entities – Market size and forecast 2022-2027 ($ million)
Exhibits45: Chart on Government entities – Year-over-year growth 2022-2027 (%)
Exhibits46: Data Table on Government entities – Year-over-year growth 2022-2027 (%)
Exhibits47: Chart on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospitals and clinics – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospitals and clinics – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Others – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Others – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Others – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Others – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Distribution Channel ($ million)
Exhibits56: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits58: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Chart on Geographic comparison
Exhibits61: Data Table on Geographic comparison
Exhibits62: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits63: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits67: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits68: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits69: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits70: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits72: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits74: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits83: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits84: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits85: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits86: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits87: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits88: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits89: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits90: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits92: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits94: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits95: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits96: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits97: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits98: Market opportunity By Geographical Landscape ($ million)
Exhibits99: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits100: Impact of drivers and challenges in 2022 and 2027
Exhibits101: Overview on Criticality of inputs and Factors of differentiation
Exhibits102: Overview on factors of disruption
Exhibits103: Impact of key risks on business
Exhibits104: Vendors covered
Exhibits105: Matrix on vendor position and classification
Exhibits106: AstraZeneca Plc – Overview
Exhibits107: AstraZeneca Plc – Product / Service
Exhibits108: AstraZeneca Plc – Key news
Exhibits109: AstraZeneca Plc – Key offerings
Exhibits110: Bharat Biotech Ltd. – Overview
Exhibits111: Bharat Biotech Ltd. – Product / Service
Exhibits112: Bharat Biotech Ltd. – Key news
Exhibits113: Bharat Biotech Ltd. – Key offerings
Exhibits114: CureVac AG – Overview
Exhibits115: CureVac AG – Key offerings
Exhibits116: Emergent BioSolutions Inc. – Overview
Exhibits117: Emergent BioSolutions Inc. – Product / Service
Exhibits118: Emergent BioSolutions Inc. – Key news
Exhibits119: Emergent BioSolutions Inc. – Key offerings
Exhibits120: Genexine Inc. – Overview
Exhibits121: Genexine Inc. – Product / Service
Exhibits122: Genexine Inc. – Key offerings
Exhibits123: Inovio Pharmaceuticals Inc. – Overview
Exhibits124: Inovio Pharmaceuticals Inc. – Product / Service
Exhibits125: Inovio Pharmaceuticals Inc. – Key news
Exhibits126: Inovio Pharmaceuticals Inc. – Key offerings
Exhibits127: Johnson and Johnson – Overview
Exhibits128: Johnson and Johnson – Business segments
Exhibits129: Johnson and Johnson – Key news
Exhibits130: Johnson and Johnson – Key offerings
Exhibits131: Johnson and Johnson – Segment focus
Exhibits132: Moderna Inc. – Overview
Exhibits133: Moderna Inc. – Product / Service
Exhibits134: Moderna Inc. – Key offerings
Exhibits135: Novavax Inc. – Overview
Exhibits136: Novavax Inc. – Product / Service
Exhibits137: Novavax Inc. – Key offerings
Exhibits138: Pfizer Inc. – Overview
Exhibits139: Pfizer Inc. – Product / Service
Exhibits140: Pfizer Inc. – Key news
Exhibits141: Pfizer Inc. – Key offerings
Exhibits142: Serum Institute of India Pvt. Ltd. – Overview
Exhibits143: Serum Institute of India Pvt. Ltd. – Product / Service
Exhibits144: Serum Institute of India Pvt. Ltd. – Key offerings
Exhibits145: Shenzhen Kangtai Biological Products Co. Ltd. – Overview
Exhibits146: Shenzhen Kangtai Biological Products Co. Ltd. – Product / Service
Exhibits147: Shenzhen Kangtai Biological Products Co. Ltd. – Key offerings
Exhibits148: Sinovac Biotech Ltd. – Overview
Exhibits149: Sinovac Biotech Ltd. – Product / Service
Exhibits150: Sinovac Biotech Ltd. – Key offerings
Exhibits151: Tadbir innovation pharmaceutical Co. – Overview
Exhibits152: Tadbir innovation pharmaceutical Co. – Product / Service
Exhibits153: Tadbir innovation pharmaceutical Co. – Key offerings
Exhibits154: Zydus Lifesciences Ltd. – Overview
Exhibits155: Zydus Lifesciences Ltd. – Business segments
Exhibits156: Zydus Lifesciences Ltd. – Key offerings
Exhibits157: Zydus Lifesciences Ltd. – Segment focus
Exhibits158: Inclusions checklist
Exhibits159: Exclusions checklist
Exhibits160: Currency conversion rates for US$
Exhibits161: Research methodology
Exhibits162: Validation techniques employed for market sizing
Exhibits163: Information sources
Exhibits164: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の新型コロナウイルス感染症ワクチン接種市場2023-2027(Global Covid-19 Vaccination Market 2023-2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆